长沙招聘

Role Title: Associate Scientist, Translational Medicine, R&D China

Reports to: Scientist, ND DPU

Job Purpose:

· Focus will be on in vitro assays including ELISA, FACS, cell culture, beta Imaging, and immunohistochemistry.

· Laboratory based role that requires performing a broad range of in vitro pharmacological experimental activities supporting development and validation of translatable pharmaco-dynamic biomarkers under the supervision from manager.

· Perform routine tasks at the discretion of line manager; apply alternative protocols, reports in an accurate, timely and safe manner, compliant with all internal and external policies working in a flexible manner with other scientific colleagues.

Key Responsibilities and Accountability:

· To provide daily scientific support to the progression of the Neurodegenerative DPU’s portfolio Leading negotiations and developing price agreements with key customers

Complexity:

· Working in a flexible manner with other scientific colleagues.

Specialized Knowledge:

· MSc in neuroscience, Molecular Biology, Pharmacology or related discipline.

Basic Requirements:

· Ability to work under guidance of manager and/or experts in the field and in a team environment.

· Has the aptitude to troubleshoot problems with support from manager. · Has the capacity to learn and implement novel technologies into daily activities.

· Fluency in English essential and in Mandarin would be an advantage.

· Demonstrated effective interpersonal, communications and negotiation skills required.

· Work to highest standards of safety in a lab environment and direct others to these standards

Preferred Requirements:

· Sound theoretical knowledge of neurodegenerative disease mechanisms. Pharmaceutical or Contract Research Organization Industry experience

GlaxoSmithkline/葛兰素史克
作为世界领先的制药业巨擘，葛兰素史克公司秉承以研究开发为基础的一贯理念，凭藉公司本身的技术潜力和资源优势，在当今瞬息万变的医疗保健领域保持强劲的增长势头。
葛兰素史克公司，由葛兰素威康和史克必成强强联合，于2000年12月成立。两家公司的历史均可追溯至19世纪中叶，各自在一个多世纪的不断创新和数次合并中，在医药领域都确立了世界级的领先地位。两个制药巨人的成功合并，为葛兰素史克成为行业中无可争议的领导者奠定了基础，并在全球药品市场中占据有7%的份额。
葛兰素史克公司总部设在英国，以美国为业务营运中心，在抗感染、中枢神经系统、呼吸和胃肠道/代谢四大医疗领域代表当今世界的最高水平，在疫苗领域雄居行业榜首。此外，公司在消费保健领域也居世界领先地位，主要产品包括非处方药、口腔护理品和营养保健饮料。2006年公司在全球的销售总额达232亿英镑。目前，公司在全球拥有10万余名既掌握专业技能又有奉献精神的出色员工。
全球研发中心有1万6千科学家和技术人员分布在全球许多国家。为进一步推动研发全球化，葛兰素史克(GSK)中国研发中心于2007年6月成立。中心将侧重于神经退行性病变的研究，目标是为多发性硬化病、帕金森病和阿尔茨海默氏病等严重疾病开发新药。中国研发中心将发展成有1000多科学家和技术人员的全球研发中心。中心将以科学研究为基础（science-driven），通过生物学，化学以及最新技术，创新开发新的治疗手段。中国研发中心将最终引领GSK在这一领域从识别药物靶标到后期临床研究的全球研发活动，并在中国和其他研究机构密切合作。GSK中国研发中心计划在未来10年内成长为GSK的大型研发中心之一。
更多信息请访问我们的网站：www.gsk.com or www.gskchina.com